Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Valiant Tops Tiger Cubs as Hedge Funds Ride AI, Power, and Chips to Big Gains Stephen Taub This Group Has a Road Map for TPA. Not Everyone’s Along for the Ride. James Comtois Fireside Chat: Stable Value Strategies, Navigating Uncertainty with Confidence Sponsored by Lincoln Financial